The US Oncology Network in the News

In the News

Read about us in the news to learn how the more than 1,400 physicians in The US Oncology Network advance cancer care in America.

Broadcast

OBR Daily: Dr. Robert Rifkin, Medical Director, Speculates on What Might Influence the Adoption of Biosimilars by Oncologists

OncLiveTV: Therapy Selection in BRCA-Mutated Ovarian Cancer (Panel video with Bradley J. Monk, Arizona Technology, The Network)

OncLiveTV: Adopting Neoadjuvant Therapy into Ovarian Cancer (Panel video with Bradley J. Monk, Arizona Technology, The Network) 

OncLive TV: Implications for Germline BRCA Testing in Breast Cancer (panel hosted by Dr. Joyce O’Shaughnessy)

OBR Daily: Debra Patt, MD, MPH, MBA, Explains the Benefits and Challenges Associated with Prescribing CAR-Ts

Oncology Business Review: Michael Seiden, MD, PhD, tells us how big data is helping to advance clinical progress

OncLive TV: Adjuvant Sunitinib's Role in the Treatment of RCC

American Journal of Managed Care: Dr. Linda Frisk Discusses the Role of the Pharmacist in Value-Based Care

OncLiveTV: Dr. Paulson on the Importance of Symptom Control

Oncology Tube: FDA Approval of Several CAR-T Cell Therapies - Hope to make new therapies accessible to patient

Oncology Tube: Development of a Predictive Model of MM Patient Outcomes - Based on Treatment Class Transitions using patient registry

Oncology Tube: Baseline Disease Characteristics & Diagnostic Patterns for NDMM - Observations over time in Cohort 1 and Cohort 2

Oncology Tube: Survival and Depth of Response in African American and Non-AA Patients - Conflicting data on the virulence of Myeloma for African American patients

Oncology Tube: Connect® Multiple Myeloma Patient Registry - Eventually pool data from Connect® for a larger database of registry

Oncology Tube: Carflizomib is Extraordinarily Active in Myeloma Mainstay drug for physicians and patients

Oncology Tube: Carflizomib Doing Patterns - Data presented for appropriate dosing of Carfilzomib

Oncology Tube: Poster #1 Phase 2 Study of Daratumumab+ CyBorD - Dose was split into two days to reduce infusion time

Oncology Business Review: Robert M. Rifkin, MD, on excluding transplantation from MM treatment algorithms

Oncology Business Review: Robert M. Rifkin, MD, discusses if COMPASS is close to its goal of achieving whole genome sequencing

Oncology Business Review: Robert M. Rifkin, MD, on the Connect Multiple Myeloma patient registry improving characterization

Oncology Business Review: Robert M. Rifkin, MD, on how the Connect Multiple Myeloma patient registry is helping patients

Oncology Business Review: Michael Boxer, MD, on how obinutuzumab and bendamustine impacts quality of life in CLL patients

Oncology Business Review: Michael Boxer, MD, considers broader uses for fostamatinib

Oncology Business Review: Michael Boxer, MD, on the effectiveness of fostamatinib in the maintenance of ITP responses

Oncology Business Review: Habte Yimer, MD, on daratumumab, cyclophosphamide, bortezomib, & dexamethasone in relapsed MM

Oncology Business Review: Habte Yimer, MD, considers the impact of combination obinutuzumab and bendamustine on CLL patients

Oncology Business Review: James Essell, MD, discusses the concerns for patients receiving allogeneic transplantations

Oncology Business Review: James Essell, MD, on how allogeneic transplantation is incorporated into hematologic malignancy

Oncology Business Review: John Burke, MD, on rituximab as an effective strategy after 1st line bendamustine-rituximab in FL

Oncology Business Review: John Burke, MD, lists the top findings from ASH 2017 regarding lymphoid malignancies

Oncology Business Review: John Burke, MD, on combination atezolizumab, obinutuzumab, and bendamustine in follicular lymphoma

KTNV-TV: Advances in brain cancer treatment gives patients new hope

Oncology Business Review: Debra Patt, MD, considers how community oncology contributes to clinical research advancement

Oncology Business Review: Debra Patt, MD, shares how community oncology has contributed to advances in population health

Oncology Business Review: Debra Patt, MD, elaborates on how community oncology contributes to the Cancer Moonshot

Oncology Business Review: Ben Jones shares what McKesson Specialty Health is doing to help community oncologists thrive

Oncology Business Review: Ben Jones gives advice to practices interested in advocating for community oncology

Oncology Business Review: Ben Jones on the hot policy topics impacting the delivery of quality cancer care

Oncology Business Review: Lalan Wilfong, MD, explains how OCM has impacted cancer patients in his practice

Oncology Business Review: Lalan Wilfong, MD, provides opinion on how OCM is changing his practice

Oncology Business Review: Lalan Wilfong, MD, shares lessons from his experience participating in OCM

Oncology Business Review: Debra Patt, MD, on technological advances in cancer care and community oncology

Oncology Business Review: Debra Patt, MD, on what tele-health brings to cancer care

Oncology Business Review: Debra Patt, MD, explains how data systems help with patient care delivery in community oncology

Oncology Business Review: Debra Patt, MD, explains how decision support tools improve the quality and delivery of cancer care

Oncology Business Review: Debra Patt, MD, explains using predictive analytics to improve cancer care delivery

Oncology Business Review: Diana Verrilli, McKesson Specialty Health, on how claims data can be used in the OCM model

Oncology Business Review: Diana Verrilli, McKesson Specialty Health, on how claims data is being used

Oncology Business Review: Marcus Neubauer, MD, discusses how practices and administrators can build higher pathway compliance

Oncology Business Review: Marcus Neubauer, MD, explains how clinical pathways differ from clinical guidelines

Oncology Business Review: Marcus Neubauer, MD, discusses if clinical pathways create value in cancer care

Oncology Business Review: Marcus Neubauer, MD, explains how clinical pathways save money when treating cancer

Patient Power: ASH 2016 Expert Roundtable: What does emerging CLL research mean for patients?

Oncology Tube: ASH 2016 Lymphoma News

OncLiveTV: Dr. Kolibaba on Efficacy of Entospletinib in Mantle Cell Lymphoma

OncLiveTV: Dr. Kolibaba on Entospletinib Activity in Mantle Cell Lymphoma

OncLiveTV: Dr. Kolibaba on Mechanism of Action with Entospletinib in MCL

OncLiveTV: Dr. Burke on a Study Investigating Obinutuzumab in Large B-Cell Lymphoma

healtheo360: Vital Conversations: David J. Andorsky from Rocky Mountain Cancer Centers (Part 1 of 2)

healtheo360: Vital Conversations: David J. Andorsky from Rocky Mountain Cancer Centers (Part 2 of 2)

healtheo360: Vital Conversations: Dr. Jeff Sharman from the Willamette Valley Cancer Institute and Research Center

healtheo360: Vital Conversations: Dr. Kathryn Kolibaba from Compass Oncology

healtheo360: Vital Conversations: Dr. John Burke from Rocky Mountain Cancer Centers

HemOnc Today: Symposium highlights diversity of breast cancer biology, targets

HemOnc Today: Genomic profiling may identify subset of women who benefit from extended letrozole

HemOnc Today: Combination active in subset of women with triple-negative breast cancer

HemOnc Today: Anti-CD19 CAR T cells may offer new option for difficult-to-treat patients with DLBCL

Patient Power: ASH 2016: Hodgkin Lymphoma News

Patient Power: ASH 2016: Lymphoma Research News Update

OncLiveTV: Dr. Blum on Takeaways from ABC Trials for Breast Cancer

OncLiveTV: Dr. Nicholas Robert on MA.17R Trial for Patients With Early-Stage Breast Cancer

Oncology Business Review: Debra Patt, MD, tells us how chemotherapy costs figure into total care

Patient Power: ASCO 2016 CLL Research Update

Patient Power: 2016 Lymphoma Research Update

Patient Power: ASH 2015: What Could a Second-Generation BTK Inhbitor Mean for Patients?

Patient Power: ASH 2015 Coverage: Emerging Approaches for Treatment-Resistant CML Patients

Patient Power: ASH 2015 News: Emerging Approaches for Elderly Hodgkin Lymphoma Patients

Patient Power: Dr. Jeff Sharman: My Perspective on ASH 2015 News

Patient Power: Follicular Lymphoma News From ASH 2015

OncLiveTV: Dr. Sharman on Entospletinib in Patients with CLL

OncLiveTV: Dr. Joanne Blum on the EMBRACA Trial in Metastatic BRCA-Mutant Breast Cancer

OncologyTube: Ibrutinib or Idelalisib Selecting Appropriate Therapy for Relapsed CLL

OncologyTube: Entospletinib Why It’s Different Than Fostamatinib

CLL Transformed in Last 5 Years, Hope is to Leave Chemotherapy Behind

OncologyTube: Bcl-2, BTK, and PI3 Inhibitors Among Highlights Presented at ASH 2015

Patient Power: Advances in Treating High-Risk CLL

The Today Show: Hope to it

Patient Power: What Could Emerging Immunotherapy Research Mean for Lung Cancer Patients

Patient Power: Advances in Immuno-Oncology Research

OncLiveTV: Dr. Spira on the POPLAR Study NSCLC

Fox News: Hospitals being overpaid for medical treatment?

Special Report with Bret Baier

CBS Evening News: Consumer protection on Obamacare delayed

OncLiveTV: Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer

OncLiveTV: Role of Lapatinib in HER2-Positive Breast Cancer

OncLiveTV: Dr. Vogelzang on Two Analyses of the ALSYMPCA Trial

OncUView TV: ASCO 2013 – Nicholas Vogelzang, MD, discusses Xofigo (radium Ra 223 dichloride)

OncLiveTV: Dr. O’Shaughnessy on Everolimus in Breast Cancer

OncLive TV: Managing Bone Health in Metastatic Breast Cancer

OncLiveTV: Ben Jones on the Impact of Sequestration on Reimbursement

KTNV-TV ABC 13 : Partial Breast Radiation Therapy

The Today Show: Family faces breast cancer together

WUSA9: Dr. Neelima Denduluri, Virginia Cancer Specialists, Discusses Fears Over Chemotherapy After Roberts' Announcement

ABC 15: Screening still vital in prostate cancer, Arizona doctor discusses treatments

PBS News Hour: Drug Hoarders, Manufacturing Cuts Exacerbate Shortage of Key Medications

Inside Business Reports: Advancements in Cancer Treatment and Care

One patient's path to remission and the role that US Oncology Research plays in enabling community-based oncology practices to successfully offer cutting-edge clinical trials.

21st Century Health: Innovative Cancer Treatment Solutions

WFMJ-TV NBC: Providing cancer treatment to those who cannot afford it

Bloomberg: McKesson to purchase US Oncology

 

Radio

Bark & Wag: Dr. Curtis Mack shares his story on how his dogs helped him fight cancer

Health Professional Radio: The San Antonio Breast Cancer Symposium 2017

Health Professional Radio: NERLYNX - Breast Cancer Treatment

Health Professional Radio: NERLYNX Update

The Tom Joyner Morning Show: Get Well Wednesday: Dr. Tia Olds Answers your Cancer Questions

 

Articles

OncLive: 5 Key Elements Needed to Achieve Success With the Oncology Care Model

PM360: Four Key Questions about Payer/Provider Strategies

American Journal of Managed Care (AJMC): Panelists Discuss Key Issues in Community Oncology Affecting Patients and Practices

Journal of Clinical Pathways: From Clinical Use to Reimbursement: An Update on Biosimilars in the US

OncLive: A Collaborative Model for Advanced Practice Providers Empowers Success

Journal of Clinical Pathways: Texas Oncology, Aetna Collaborate to Improve Patient Care Through Clinical Pathways

Journal of Clinical Pathways: Ehancing Care Coordination Supports Transition Toward Value-Based Care

Targeted Oncology: Panelists Highlight Ways to Ease Transition to Value-Based Care

Managed Healthcare Executive: Seven diseases benefiting from genetic tests

OncLive: Classification of Triple Negative Breast Cancer

The Hill: Unequal Medicare Payments Fuel Health Care Consolidation Trends

OncLive: Patient Collaboration Can Help Solve "Crisis" in Cancer Care

Oncology Business Review: Nicholas J. Vogelzang, MD Considers Genomics and Systemic Therapy in Advanced Prostate Cancer

Cure: FDA: Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer

OncLive: FDA Approves Frontline Abemaciclib for HR+/HER2- Advanced Breast Cancer

CURE Today: The History Behind the Development of CAR-T Cell Therapy

Radiology Today: Managing to Succeed: Advancing Value-Based Cancer Care

OncLive: Keeping a Tight Rein on Unnecessary Expenditures in Oncology Practice

CURE Today: MSI-H Status: What you need to know

ASH Clinical News: What are Biosimilars?

HemOnc Today: Addition of daratumumab to chemotherapy doubles PFS in transplant-ineligible newly diagnosed myeloma

Oncology Times: Development of Neratinib for Early-Stage HER2+ Breast Cancer Patients

OncLive: Von Hoff's Quest for a Cure in Pancreatic Cancer

The ASCO Post: Where Are We Now in Triple-Negative Breast Cancer?

Managed Healthcare Executive: Four oncology treatment advances to watch

Specialty Pharmacy News: CMS's Oncology Care Model Has Issues, But Participants Say Care Has Improved

HemOnc Today: WHO creates pilot program to use biosimilars to address ‘prohibitively expensive’ cancer drugs

HemOnc Today: The US Oncology Network boot camp provides expertise, gathers feedback about value-based care

OncLive: Angiogenesis Inhibitor Tested in Mesothelioma Trial

Oncology Business Management: Artificial Intelligence Is Still a Long Way From Understanding the Subtlety of a Texas Metaphor

Oncology Times: Managing the Complexities of Cancer Care With Information Technology

Oncology Business Management: MedPAC's Latest Part B Proposals Would Raise the Cost of Care

Morning Consult: Modernize Medicare With Site Neutral Payment

Morning Consult: Medicare Proposal to Better Align Payments Deserves Broad Support

Las Vegas Review-Journal: New treatments give hope to patients with tumors like McCain’s

Targeted Oncology: O'Shaughnessy Shares Novel Therapeutic Strategies for Treating Metastatic TNBC

OncologyLive: From Bench to Bedside: O'Shaughnessy Keeps Patients in Focus

OncologyLive: Novel Therapeutic Strategies for Metastatic TNBC

HemOnc Today: Supreme Court ruling on biosimilars ‘a win’ for patients

HemOnc Today: Unknowns of interchangeability likely not problematic with monitoring, FDA guidance

Pharmaceutical Commerce: New science energizes the cancer market

CenterWatch: US Oncology Research, Epizyme collaborate

HemOnc Today: Perspective - Tailored breast cancer survivorship plans improve implementation, adherence

Las Vegas Business Press: Comprehensive Cancer Centers holds rare clinical trials

Vancouver Business Journal: Compass Oncology: Serving community with cutting-edge treatment

Oncology Practice Management: Best Practices in Oncology an Evolving Process

American Journal of Managed Care: Oncologists Believe Achieving Cancer Moonshot Goals Should Start in the Community

HIStalk: Carrot or Stick? Physician Compensation in Value-Based Cancer Care Delivery

Oncology Nursing News: Diagnosing and Treating Patients with Neuroendocrine Tumors and Carcinoid Syndrome

WVEC-TV: Clinical trials expand treatment options for cancer patients in Hampton Roads

ACCC Buzz: What Happened in Vegas: Highlights from the 2017 Cancer Center Business Summit

Las Vegas Review-Journal: Beloved doctor Nicholas Vogelzang won't stop fighting cancer

E News: Shannen Doherty completes radiation therapy and pays tribute to another cancer doctor and "Maggie"

Oncology Business Management: Joining Forces Without Loss of Independence

Oncology Practice Management: Physician-Owned, Community-Based Oncology Practices: The US Oncology Network Model

Managed Healthcare Executive: Watch list 2017: Top therapeutic areas

Specialty Pharmacy News: CMS Launches 'Transformative,' 'Monumental' Oncology Care Model

Denver Business Journal: Denver doctor on leading edge of treating neuroendocrine cancer

U.S. News & World Report: What to Look for in a Hospital if You Need Lung Cancer Surgery

U.S. News & World Report: Stomach Cancer: Awareness and Advances Needed

HIStalk: Physician Engagement in Cancer Care Delivery Redesign

OncologyLive: Oncology Practice Vitality Depends on Leadership

Lung Disease News: Center Enrolls First Lung Cancer Patient in Advanced Phase 3 Clinical Trial

Specialty Pharmacy News: With CMS's OCM Set to Start July 1, The US Oncology Network Preps Practices

HealthLeaders: Oncology Care Model Kicks Off

Targeted Oncology: Anthracycline Regimen Superior in HER2-Negative Breast Cancer

The Hill: Congress: Don't dial back site-neutral payment reforms

STAT News: Breast cancer study shows benefit to extended treatment with aromatase inhibitors

Oncology Business Management: Some Prefer Pay Cuts to Inflexible CMS Metrics

Oncology Nurse Advisor: Anthracycline-based Regimens Superior in Treating High-Risk, HER2-negative Breast Cancer

Pharmaceutical Commerce: Oncology: a new era in therapies; same cost concerns

Managed Healthcare Executive: New oncology payment model accelerates shift to value

ASCO Connection: Five Difficult Interview Questions Oncology Fellows May Encounter: The Do's and Don'ts

Prevention.com: 7 Worst Things People Lie To Their Doctors About

Reader's Digest Online: 17 Common Lies You Tell Your Doctor (And Why You Need to Just Stop)

HIStalk: Empowering Value-Based Technologies with Standardization, Agreement, and Leadership

Oncology Business Management: Top 3 Must Do's to Prepare for Managed Care in 2016

HealthLeaders: Oncology Bundling Model Aims to Incentivize Doctors

SheKnows.com: Signs your migraine is more than just a minor headache

SheKnows.com: Nine health myths about your boobs you can finally put to rest

Ocala Star Banner: Promising new cancer drug helping Ocala woman

OncologyLive: Oncologists Must Take Lead Role in Developing Clinical Pathways

Oncology Times: ASCO Issues Recommendations to Improve Oncology Clinical Pathways

OncologyLive: Tackling Challenging Patient Populations in DLBCL

OncologyLive: Frontline Brentuximab Vedotin Generates 76% Complete Remission Rate in DLBCL

HemOnc Today: Brentuximab vedotin combinations yield encouraging response rates in elderly Hodgkin's lymphoma

Oncology Business Management: Compatibility Check: Can Precision Medicine and Pathways Co-Exist?

Oncology Business Review: Extending and Enhancing Patient Care Beyond the Office with Patient Portals

Fox News: Moms with BRCA breast cancer gene mutations face tough decisions

Oncology Times: Critiquing ASCO's Cancer Care Value Plan

HealthDay News: Could Common Diapetes Drugs Help Fight Leukemia?

LiveScience.com: Skeletal System: Facts, Function & Diseases

HealthDay: 1 in 3 Women Survive Ovarian Cancer a Decade or More: Study

OncologyLive: O'Shaughnessy Details Strategies to Strengthen ER Blockade in MBC

Oncology Business Management: CMS Standards for Reporting Call for Advanced Technology, Training

OncologyLive: Shifting Reform Landscape Is Perilous for Small Practices

HealthDay News: Cell Damage Occurs When People Have CT Scans: Study

LiveScience.com: Lymphatic System: Facts, Functions & Diseases

Yahoo!: One Woman's Story Highlights the Hidden Skin Cancer Risks for People of Color

U.S. News & World Report: Preparing for a Baby After Cancer

Everyday Health: First Breast, Now Lung: One Woman's Fight Against Cancer

Oncology Business Management: Physician Quandary: Data Shortage, Surfeit Impinge on Precision Medicine

Oncology Business Management: More Effort Needed to Understand Value Breadth of Molecular Testing

Managed Care: Biosimilars Change the Market But Still Face Many Hurdles

BlackDoctor.org: Condition Critical: Fighting Breast & Cervical Cancers In Black Women

Roll Call: A Common-Sense Medicare Solution: Site-Neutral Payment Reform | Commentary

Examiner.com: Joel M. Schwartz, DO increases your knowledge regarding skin cancer awareness

Oncology Times: CLL: New Drugs Bring Paradigm Shift for High-Risk Disease

Specialty Pharmacy Continuum: Cancer Drugs Help SPs Show Their Value

Oncology Business Review: Novel Therapies for Leukemia Attract Attention at ASCO 2014

Bloomberg: Bristol-Myers, Merck Immune Therapy Promising in Cancer Trials

BioNews Texas: New Clinical Trial By US Oncology Research Tests Chemotherapy-Induced Hair Loss Therapy

Albany Business Review: Former executive at Albany area's largest cancer-treatment center gets regional position

HealthDay News: Popular Crohn's, Colitis Drugs Not Linked to Short-Term Cancer Risk: Study

The New York Times: Study May Alter Approach to Prostate Cancer

OncologyLive: Vogelzang Sees Early Chemo Strategy as Landmark Change in Prostate Cancer Therapy

Portland Business Journal: Oregon docs find good news with cancer risk assessment

BioNews Texas: Gastrointestinal Cancers Studied Using Caris Life Science’s Technology, Presented at ASCO Meeting

Las Vegas Review-Journal: Cancer anxiety a factor in treatment

Roll Call: It's Time to Level the Playing Field in Cancer Care

Pharmaceutical Commerce: Bending the cost curve in oncology

The Journal of Community and Supportive Oncology: Taking on racial and ethnic disparities in cancer care

HealthDay News: New Colon Polyp Removal Method May Be Easier on Patients

HealthDay News: HPV-Linked Oral Cancers May Not Be 'Contagious'

Forbes: Death Rates From Pancreatic Cancer Continue To Climb: Most Other Cancers Declining In Europe

Forbes: Is There A Link Between Prostate Cancer And Chronic Inflammation?

Forbes: Improved Survival For Men With Localized Prostate Cancer: Six Months Hormonal Treatment Combined With Radiation

HealthDay News: Experimental Breast Cancer Drug Seems Safe, Effective for Advanced Disease

The Cancer Letter: What the Physician Pay Report Won't Tell You

Modern Healthcare: Denying access to big cancer centers may undermine narrow networks

Forbes: New Urine Test Accurately Predicts Recurrence Of Bladder Cancer

Forbes: Guideline Updated Regarding Role of Sentinel Lymph Node Biopsy In Early Stage Breast Cancer

HealthDay News: Targeted Radiation Might Help Fight Advanced Breast Cancer: Study

HealthDay News: New Guidelines Might Limit Need for Lymph Node Removal for Breast Cancer

HealthDay News: Colon Cancer Cases Decline for Older Americans

Forbes: How Should We Manage Early Prostate Cancer?

OncologyLive: Study Supports First-Line Eribulin Therapy in Metastatic Breast Cancer

HealthDay News: Ovarian Cancer Gene May Point to Early Removal of Ovaries: Study

OncologyLive: PARP Inhibitor BMN 673 Advances in Breast Cancer Study

HealthDay News: Ovarian Cancer Gene May Point to Early Removal of Ovaries: Study

OncologyLive: PARP Inhibitor BMN 673 Advances in Breast Cancer Study

The Hill: Equalize payments for cancer care

Forbes: Cervical Cancer: Detectable and Preventable

Community Oncology: Policy prescriptions to fix our ailing delivery system

Forbes: Novel Genetic Test For Breast Cancer May Guide MRI Screening In Women With Intermediate Lifetime Risk

HealthDay News: Experimental Vaccines May Extend Life in Pancreatic Cancer

HealthDay News: Blood Test Might Help Spot Pancreatic Cancer Early

Las Vegas Review-Journal: Brave risk helps women cheat death

Value-Based Cancer Care: New Collaborative Advance Care Planning Program for Patients with Cancer Enhances Quality while Mitigating Costs

Roll Call: Cancer Care Rests in the Community -- and in Logical Medicare Payment Policies | Commentary

BioNews Texas: Austin’s XBiotech Set To Launch Phase III Trial Collaboration with US Oncology Research for Anti-Cancer Drug Xilonix

Las Vegas Review-Journal: Survivor spirit: Summerlin mom makes most of life after Stage 4 breast cancer

Modern Healthcare: Seiden named CMO of McKesson division, oncology group

The Washington Post: Oncofertility offers new options for young women with cancer who want to have kids

Managed Care: Health Plans Lag Providers On Molecular Profiling

Vegas Inc: Patient profile: A conversation with Paul Bodner

MedPageToday: Oncology Clinics Caught in Financial Vise

The Health Journal : Genetic Testing: Knowing The Family Tree and Family Genes

Specialty Pharmacy News: Molecular Diagnostics Initiative Should Improve Care, Reduce Costs

MedPage Today: No Excess Risk of AML, MDS after Chemo

Cancer Network: ASCO Breast: DNA-Damaging Therapies Emerging as Possible Triple-Negative Breast Cancer Therapies

The Courier of Montgomery County: McKesson, US Oncology employees make 750 care packages for military

Medscape: The Right EHR for an Oncology Practice

Oncology Times: Pathway or Pathways? Major Pennsylvania Insurer Takes a Stand, But Now a Long-Time Partnership Has Turned Difficult

Biotechnology Healthcare: Will Clinical Pathways Work?

The New York Times: Insurers Test New Cancer Pay Systems

The Wall Street Journal: In Treating Cancer, Insurer Tries New Way to Pay Docs

Chicago Tribune: Patient Assistance Support

Bureau of National Affairs: BNA Q & A: Risk Contracting Model for Oncologists and Payers

HemOnc Today: Small cell lung cancer requires complex therapeutic strategies

Tyler Morning Telegram: Clinical Trials Pivotal In Drug Development

Information Week: BI Made Easier For Healthcare

Odessa American Daily: Clinical Trials

HemOnc Today: REMS for ESAs: The FDA mandated program is under scrutiny

HemOnc Today: Hematologic Malignancies

Cancer Network: Evidence-based pathway plus electronic health records system matches major trials for colorectal cancer treatment outcomes

North Bay Business Journal: Redwood Regional joins nationwide network of oncologists

Houston Business Journal: Collaboration Creates Cancer Center

Woodlands Online: Memorial Hermann, Texas Oncology And US Oncology Partner

Las Vegas Review Journal: TREATMENT QUALITY: Care, research attract visitors

Dallas Morning News: Cancer doctors weigh in with opinions on travel

Dallas Morning News: The trip treatment: Traveling during cancer care

Oncology Times: Cancer Care Pathways Catching on with Payers

US Oncology’s Innovent Oncology was featured in a story on pathways in the third article of a series carried in Oncology Times. The article shows a fair balance between Innovent Oncology, P4 healthcare and Via Oncology.

Pharmawire article on Celgene's Revlimid

Pharmawire article on melanoma May 2010

Houston Business Journal: US Oncology unveils new brand campaign

Pharmawire article: Poniard pushes forward with picoplatin in small cell lung cancer despite prior failure; oncologists cautious about success

Pharmawire article: Abraxis: Abraxane must show major clinical benefit over generic paclitaxel for widespread use, physicians say

Pharmawire article: Eisai and Supergen's Dacogen expected to demonstrate positive results in DACO-016 trial in AML, hematologists/oncologists say

Pharmawire article: Sunesis’ voreloxin offers modest response rates, but encouraging toxicity in AML – hematologists

Wall Street Journal article Women's Health

Nevada Business Magazine: Nevada Business Magazine - Healthcare Heroes

James Kilber profile for Top Administrator in Southern Nevada (page 7)

Nevada Business Magazine: Nevada Business Magazine - Healthcare Heroes

Dr. Mary Ann Allison profile for Caregiver of the Year in Southern Nevada (page 8)

Tampa Bay Times: Florida Cancer Affiliates opens site in New Port Richey

US News & World Reports: Experimental Drugs Do Battle Against Advanced Prostate Cancer

Reuters: Breast cancer kills older women more often

 

Studies

Journal of Oncology Practice: Opening the Black Box: The Impact of an Oncology Management Program Consisting of Level I Pathways and an Outbound Nurse Call System

The New England Journal of Medicine: Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

The New England Journal of Medicine: Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Managed Care: Molecular Monitoring of Response In Patients With Chronic Myeloid Leukemia

Journal of Oncology Practice article: Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting

 

Podcasts

Journal of Clinical Pathways: OCM Pilot Program Successes at The US Oncology Network

Podcast from HemOncTown eNews featuring US Oncology Chief Scientific Officer Daniel Von Hoff, M.D., F.A.C.P.

The ASCO 2010 David A. Karnofsky Memorial Award recipient reflects on the future of oncology therapeutics and logistics.
 

Blogs

Software Advice: US Oncology iKnowMed EHR Medical Software

ASCO 2010-Cabazitaxel second line for prostate castration resistant cancer